Fast-acting, FDA-approved treatment for depression with suicidal ideation.
What this means, clinically.
-
Spravato is specifically FDA-approved for MDD with acute suicidal ideation or behavior.
-
Rapid onset means meaningful relief can begin within hours of the first session.
-
Clinically supervised in our Port Chester clinic — every session monitored by our team.
-
Most PPO insurance plans cover this indication — we verify coverage in advance.
Why speed matters, and how Spravato delivers it.
-
FDA-approved specifically for MDD with acute suicidal ideation since 2020.
-
Nasal spray administered in-office — no IV required.
-
Monitored for a minimum of 2 hours after each session per FDA protocol.
-
Can be used alongside your existing oral antidepressant or as a standalone therapy.
-
Covered by most PPO insurance plans — we handle verification before your first visit.
Important: PMC Psychedelic is not an emergency or crisis service.
Who is a good candidate for this treatment?
-
Adults 18 and older with a diagnosis of major depressive disorder.
-
Currently experiencing suicidal ideation or behavior.
-
Medically stable and appropriate for outpatient care — not requiring hospitalization.
-
Able to attend in-office sessions (approximately 2 hours each) and arrange a ride home.
-
Hold a PPO insurance plan, or prepared to pay out of pocket for Ketamine IV as an alternative.
Common questions.
Spravato is FDA-approved for this specific indication and has been studied in patients with active suicidal ideation. Every session at PMC is supervised by our clinical team. Dr. Rueda evaluates each patient before treatment begins to confirm they are appropriate for outpatient care. We do not treat patients who require hospitalization.
Yes — Spravato is FDA-approved for MDD with acute suicidal ideation, and most PPO insurance plans cover this indication. We verify your coverage before your first appointment. Call us to begin the verification process.
In most cases, yes. Spravato is approved for use alongside an oral antidepressant. Dr. Rueda will review your full medication list during your evaluation and advise accordingly.
